SITC Cancer Immunotherapy Guidelines - Non-Small Cell Lung Cancer (NSCLC) Webinar

When:  Sep 13, 2018 from 1:00 PM to 2:00 PM (ET)

Join leading experts in cancer immunotherapy for the SITC Cancer Immunotherapy Guidelines - Non-Small Cell Lung Cancer (NSCLC) Webinar.

sitc_log_color.pngThis FREE CME-, CNE-, CPE-certified webinar is a chance for clinicians, pharmacists, PAs, NPs, and RNs to learn about the recommendations from the recently published guideline, The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).

Register Now Download Promotional Flyer

The webinar faculty will present and discuss:

  • The role of immunotherapy for the treatment of NSCLC
  • The role of patient biomarker testing for prognostic use as well as optimizing treatment selection
  • Unique disease cases that may require adaption of immunotherapy utilization
  • How best to manage immune-related adverse events

A dedicated question-and-answer session during the webinar will provide an opportunity for attendees to converse with the faculty and ask questions about the guideline recommendations.


Webinar Faculty:

  • Roy S. Herbst, MD, PhD – Yale Cancer Center
  • Julie R. Brahmer, MD – Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Patrick Forde, MD – Johns Hopkins University
  • Scott N. Gettinger, MD – Yale Cancer Center 
Click HERE to register for the webinar!


Webinar Agenda:
1:00–1:05 p.m. EDT  Welcome and introductions
1:05–1:40 p.m. EDT  Presentation and discussion of Guideline content 
1:40–1:55 p.m. EDT  Question and answer session
1:55–2:00 p.m. EDT  Closing remarks


Continuing Education Credits are available for physicians, nurses and pharmacists. 

Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer

#CME #CPE #CNE #Biomarkers #LungCancers #Webinar #Oncologist #Clinician #Nurse #Pharmacist #AdverseEvents #CancerImmunotherapyGuidelines